Toxoplasmosis in a patient with non-Hodgkin's lymphoma: The need for a good differential diagnosis

Clinical Eye and Vision Care

Volumn 12, Issue 1-2, 2000, Pages 61-69

  King, Rebecca S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cytomegalovirus retinitis; Endogenous Aspergillus endophthalmitis; Endogenous bacterial endophthalmitis; Non Hodgkin's lymphoma; Toxoplasmosis

Indexed keywords

AZITHROMYCIN; CHLORAMBUCIL; COTRIMOXAZOLE; DOXYCYCLINE; FLUCONAZOLE; PREDNISOLONE ACETATE; PREDNISONE; SCOPOLAMINE; TIMOLOL MALEATE;

AGED; ARTICLE; CASE REPORT; CHORIORETINITIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNE DEFICIENCY; NONHODGKIN LYMPHOMA; RETINA DISEASE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0034162436     PISSN: 09534431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-4431(99)00046-6     Document Type: Article

References (60)

1. Nicolle C., Manceaux L. Sur une infection a corps de Leishman (ou organismes voisins) du gondi. C R Acad Sci. 147:1908;736.
2. Splendore A. Un nuovo protozoa parassita de' conigli incontrato nelle lesioni anatomiche d'une malatti che ricorda in molti punti il Kala-azar dell'umo. Nota preliminaire pel. Rev Soc Sci Sao Paulo. 3:1908;109-112.
3. Janku J. Pathogenesa a patologicka anatomie tak nazvanecho vrozeneho kolobomu zlute skvrny v oku normalne velikem a microphthalmickem s nalezem parasitu v sitnici. Cas Lek Ces. 62:1923;1021-1138.
4. Pavesio C.E., Lightman S. Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol. 80:1996;1099-1107.
5. Bornand J.E., de Gottrau P. Uveitis: is ocular toxoplasmosis only a clinical diagnosis? Ophthalmologica. 211:1997;87-89.
6. Rothova A. Ocular involvement in toxoplasmosis. Br J Ophthalmol. 77:1993;371-377.
7. Choi W.Y., Nam H.W., Kwak N.H. et al. Food-borne outbreaks of human toxoplasmosis. J Infect Dis. 175(5):1997;1280-1282.
8. Bowie W.R., King A.S., Werker D.H. et al. Outbreak of toxoplasmosis associated with municipal drinking water. Lancet. 350:1997;173-177.
9. Burnett A.J., Shortt S.G., Isaac-Renton J., King A., Werker D., Bowie W.R. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 105(6):1998;1032-1037.
10. Pivetti-Pezzi P., Accorinti M., Tamburi A., Ciapparoni V., Abdulaziz M.A. Clinical features of toxoplasmic retinochoroiditis in patients with acquired immunodeficiency syndrome. Ann Ophthalmol. 26:1994;73-84.
11. Akstein C., Wilson L., Teutsch S.M. Acquired toxoplasmosis. Ophthalmology. 89(12):1982;1299-1302.
12. Ronday M.J., Luyendijk L., Baarsma G.S., Bollemeijer J.G., Van der Lelij A., Rothova A. Presumed acquired ocular toxoplasmosis. Arch Ophthalmol. 113(12):1995;1524-1529.
13. Montoya J., Remington J. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. CID. 23(8):1996;277-282.
14. Hausmann N., Richard G. Acquired ocular toxoplasmosis. Ophthalmology. 98(11):1991;1647-1651.
15. O'Connor G.R. Ocular toxoplasmosis. Jpn J Ophthalmol. 19:1975;1-24.
16. O'Connor G.R. The influence of hypersensitivity on the pathogenesis of ocular toxoplasmosis. Trans Am Ophthalmol Soc. 68:1970;501-547.
17. Theodossiadis P., Kokolakis S., Ladas I., Kollia A.C., Chatzoulis D., Theodossiadis G. Retinal vascular involvement in acute toxoplasmic retinochoroiditis. Int Ophthalmol. 19:1995;19-24.
18. Kyrieleis W. Uber atypissch Gefasstuberkulose der Netzhaut (Periarteritis 'nodosa' tuberculosa). Arch Augenheilkd. 107:1933;182-190.
19. Gass J.D.M. Stereoscopic atlas of macular disease: diagnosis and treatment. 3rd ed. 1987;Mosby, St. Louis.
20. Gaynon M.W., Boldrey E.E., Strahlman E.R., Fine S.L. Retinal neovascularization and ocular toxoplasmosis. Am J Ophthalmol. 98:1984;585-589.
21. Williamson T., Meyers P. Branch retinal artery occlusion in toxoplasmosis retinochorioditis. Br J Ophthalmol. 75:1991;253.
22. Gentile R.C., Berinstein D.M., Oppenheim R., Walsh J.B. Retinal vascular occlusions complicating acute toxoplasmic retinochoroiditis. Can J Ophthalmol. 32:1997;354-358.
23. Martin W.G., Brown G.C., Parrish R.K., Naidoff M.A., Benson W.E. Ocular toxoplasmosis and visual field defects. Am J Ophthalmol. 90(1):1980;25-29.
24. Hoerni B., Vallat M., Durand M., Pesme D. Ocular toxoplasmosis and Hodgkin's disease: report of two cases. Arch Ophthalmol. 96(1):1978;62-63.
25. Elkins B.S., Holland G.N., Opremcak M. et al. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology. 101(3):1994;499-507.
26. Parke D.W., Font R.L. Diffuse toxoplasmic retinochoroiditis in a patient with AIDS. Arch Ophthalmol. 104:1986;571-575.
27. Schuman J., Orellana J., Friedman A. et al. Acquired immunodeficiency syndrome: cytomegalovirus, Candida albicans, toxoplasmosis, and Pneumocystis carinii. Sur Ophthalmol. 31:1987;384-410.
28. Pomeroy C., Noble R., McCormick M., Young B. Ocular toxoplasmosis as the presenting manifestation of human immunodeficiency virus infection. Clin Infect Dis. 24(4):1997;745-746.
29. Mets M.B. et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 122:1996;309-324.
30. Guex-Crosier Y., Auer C., Bernasconi O., Herbort C.P. Toxoplasmic retinochoroiditis: resolution without treatment of the perilesional satellite dark dots seen by indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol. 236(6):1998;476-478.
31. Bernasconi O., Auer C., Herbort C. Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography. Ocul Immunol Inflamm. 5(3):1997;207-211.
32. Schwab J. The epidemiologic association of Fuch's heterochromic iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol. 111:1991;356-362.
33. Friedman C., Knox D. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 81:1969;481-493.
34. Doft B., Gass J. Outer retinal layer toxoplasmosis. Graefes Arch Clin Exp Ophthalmol. 224(1):1986;78-82.
35. Engstrom R., Holland G., Nussenblatt R., Jabs D. Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 111:1991;601-610.
36. Rothova A. et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol. 115:1993;517-523.
37. O'Connor G. Manifestations and management of ocular toxoplasmosis. Bull NY Acad Med. 50:1974;192-210.
38. Morhun P., Weisz J., Elias S., Holland G. Recurrent ocular toxoplasmosis in patients treated with systemic corticosteroids. Retina. 16:1996;383-387.
39. Colebunders R., Mathijs R. Ocular toxoplasmosis treated with pyrimethamine. Am J Ophthalmol. 93(3):1982;371-372.
40. Lakhanpal V., Schocket S., Nirankari V. Clindamycin in the treatment of toxoplasmic retinochoroiditis. Am J Ophthalmol. 95(5):1983;605-613.
41. Guldsten G. Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis. Acta Ophthalmol. 61(1):1983;51-57.
42. Rothova A., Bosch-Driessen L., van Loon N., Treffers W. Azithromycin for ocular toxoplasmosis. Br J Ophthalmol. 82(11):1998;1306-1308.
43. Pearson P., Piracha A., Sen H., Jaffe G. Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology. 106(1):1999;148-153.
44. Spencer C., Goa K. Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections. Drugs. 50(1):1995;176-196.
45. Vergani P., Ghidini A., Ceruti P. et al. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone. Am J Reprod Immunol. 39(5):1998;335-340.
46. Georgiev V. Management of toxoplasmosis. Drugs. 48(2):1994;179-188.
47. Khan A., Slifer T., Araujo F., Remington J. Trovafloxacin is active against Toxoplasmosis gondii. Antimicrob Agents Chemother. 40(8):1996;1855-1859.
48. Ronday M., Ongkosuwito J., Rothova A., Kijlstra A. Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis. Am J Ophthalmol. 127(3):1999;294-300.
49. Ashburn D., Joss A., Pennington T., Ho-Yen D. Do IgA, IgE, and IgG avidity tests have any value in the diagnosis of toxoplasma infection in pregnancy? J Clin Pathol. 51(4):1998;312-315.
50. Norose K, Tokushima, Yano A. Quantitative polymerase chain reaction in diagnosing ocular toxoplasmosis. Am J Ophthalmol 1996;121[4]:441-442.
51. Ioachim H. Lymph node biopsy. 1982;J.B. Lippincott Company, New Philadelphia.
52. Kahi S. Rapid flow cytometry in toxoplasmosis. Clin Diagn Lab Immunol. 5(6):1998;745-748.
53. Davis J., Viciana A., Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol. 124:1997;362-372.
54. Weishar P., Flynn H., Murray T. et al. Endogenous Aspergillus endophthalmitis. Ophthalmology. 105(1):1998;57-65.
55. Char D., Ljung B., Milleer T., Phillips T. Primary intraocular lymphoma diagnosis and management. Ophthalmology. 95(5):1988;625-630.
56. Verbraeken H., Hanssens M., Priem H., Lafaut B., De laey J. Ocular non-Hodgkin's lymphoma: a clinical study of nine cases. Br J Ophthalmol. 81:1997;31-36.
57. Jabs D., Enger C., Bartlett J. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 107:1989;75-80.
58. Skolnik P. et al. Dual infection of retina with human immunodeficiency virus type 1 and cytomegalovirus. Am J Ophthalmol. 107:1989;361-372.
59. Kresloff M., Castellerin A., Zourbin M. Endophthalmitis. Surv Ophthalmol. 43(3):1998;193-224.
60. Greenwald M., Wohl L., Sell C. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Sur Ophthalmol. 31:1986;81-101.